Follow
Ian Driver
Ian Driver
Gordian Biotechnology
Verified email at gordian.bio
Title
Cited by
Cited by
Year
Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity
KK Quy H. Nguyen, Nicholas Pervolarakis, Kerrigan Blake, Dennis Ma, Ryan ...
Nature Communications, 2018
3082018
Local lung hypoxia determines epithelial fate decisions during alveolar regeneration
Y Xi, T Kim, AN Brumwell, IH Driver, Y Wei, V Tan, JR Jackson, J Xu, ...
Nature cell biology 19 (8), 904-914, 2017
2252017
Recruited monocytes and type 2 immunity promote lung regeneration following pneumonectomy
AJ Lechner, IH Driver, J Lee, CM Conroy, A Nagle, RM Locksley, JR Rock
Cell stem cell 21 (1), 120-134. e7, 2017
2122017
Prospective isolation of NKX2-1–expressing human lung progenitors derived from pluripotent stem cells
F Hawkins, P Kramer, A Jacob, I Driver, DC Thomas, KB McCauley, ...
The Journal of clinical investigation 127 (6), 2277-2294, 2017
1972017
A transient niche regulates the specification of Drosophila intestinal stem cells
D Mathur, A Bost, I Driver, B Ohlstein
Science 327 (5962), 210-213, 2010
1932010
Injury-induced BMP signaling negatively regulates Drosophila midgut homeostasis
Z Guo, I Driver, B Ohlstein
Journal of Cell Biology 201 (6), 945-961, 2013
1572013
High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth
BM Rao, I Driver, DA Lauffenburger, KD Wittrup
Biochemistry 44 (31), 10696-10701, 2005
812005
Persistent pathology in influenza-infected mouse lungs
CM Kanegai, Y Xi, ML Donne, JE Gotts, IH Driver, G Amidzic, AJ Lechner, ...
American journal of respiratory cell and molecular biology 55 (4), 613-615, 2016
702016
An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis
S Wang, K Li, E Pickholz, R Dobie, KP Matchett, NC Henderson, ...
Science translational medicine 15 (677), eadd3949, 2023
602023
Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor α-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect
BM Rao, I Driver, DA Lauffenburger, KD Wittrup
Molecular pharmacology 66 (4), 864-869, 2004
512004
LILRB1 blockade enhances bispecific T cell engager antibody–induced tumor cell killing by effector CD8+ T cells
A Kim, CJ Han, I Driver, A Olow, AK Sewell, Z Zhang, W Ouyang, JG Egen, ...
The Journal of Immunology 203 (4), 1076-1087, 2019
352019
Specification of regional intestinal stem cell identity during Drosophila metamorphosis
I Driver, B Ohlstein
Development 141 (9), 1848-1856, 2014
292014
Dynamic changes in the regulatory T-cell heterogeneity and function by murine IL-2 mutein
DR Lu, H Wu, I Driver, S Ingersoll, S Sohn, S Wang, CM Li, H Phee
Life Science Alliance 3 (5), 2020
132020
Increased Affinity of Interleukin-2 Ligand to the Interleukin-2 α-Receptor Leads to Increased Ligand Persistance and Cell Growth
I Driver
MIT Undergraduate Research Journal 11, 48-52, 2004
22004
A Discovery Platform that Screens Thousands of Gene Therapy Candidates in a Single Animal
MB Jensen, C Carrico, I Chandrakumar, I Driver, D Fuentes, A Kuwahara, ...
MOLECULAR THERAPY 28 (4), 71-71, 2020
12020
Correction: LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells
A Kim, CJ Han, I Driver, A Olow, AK Sewell, Z Zhang, W Ouyang, JG Egen, ...
The Journal of Immunology 203 (7), 2023-2024, 2019
12019
AN AUTOCRINE SIGNALING CIRCUIT IN HEPATIC STELLATE CELLS UNDERLIES ADVANCED FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS
S Wang, K Li, E Pickholz, R Dobie, NC Henderson, C Carrico, I Driver, ...
HEPATOLOGY 76, S425-S426, 2022
2022
Gene Therapy for Complex Disease: In Vivo Pooled Screening Predicts Clinical Outcomes In Steatohepatitis
A Araki, MB Jensen, C Carrico, L Chio, I Driver, D Fuentes, A Kuwahara, ...
MOLECULAR THERAPY 30 (4), 474-475, 2022
2022
A DISCOVERY PLATFORM THAT SCREENS THOUSANDS OF THERAPEUTIC CANDIDATES IN A SINGLE ANIMAL MODEL
MB Jensen, C Carrico, L Chio, I Driver, D Fuentes, A Kuwahara, F LePort, ...
HEPATOLOGY 74, 1128A-1128A, 2021
2021
FGF19 Gene Therapy Reduces Steatosis but Not Inflammation and Fibrosis in Two Mouse Models of Non-Alcoholic Steatohepatitis
MB Jensen, C Carrico, L Chio, I Driver, D Fuentes, A Kuwahara, F LePort, ...
MOLECULAR THERAPY 29 (4), 249-249, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20